(Q43614971)

25 November 2017

title

Donepezil in the treatment of opioid-induced sedation: report of six cases (English)

1 reference

25 November 2017

0 references

Slatkin NE

1

1 reference

25 November 2017

Rhiner M

series ordinal

2

1 reference

25 November 2017

Bolton TM

series ordinal

3

1 reference

25 November 2017

publication date

1 May 2001

1 reference

Journal of Pain and Symptom Management

25 November 2017

published in

1 reference

25 November 2017

volume

21

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

425-438

1 reference

Dextroamphetamine with Morphine for the Treatment of Postoperative Pain

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

The cognitive effects of the administration of narcotic analgesics in patients with cancer pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Driving ability in cancer patients receiving long-term morphine analgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Reversible, narcotic-associated mental status impairment in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Cognitive failure in patients with terminal cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Organic brain syndromes and opioid administration for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Factors hindering patients' use of medications for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Barriers to effective cancer pain management: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Cognitive functions of cortical acetylcholine: toward a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Acetylcholine in mind: a neurotransmitter correlate of consciousness?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Scopolamine disrupts maintenance of attention rather than memory processes

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Cholinergic dysfunction in diseases with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Microdialysis of the pontine reticular formation reveals inhibition of acetylcholine release by morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

The carbachol-induced enhancement of desynchronized sleep signs is dose dependent and antagonized by centrally administered atropine.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

DEPRESSION BY MORPHINE AND CHLORALOSE OF ACETYLCHOLINE RELEASE FROM THE CAT'S BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Morphine-naloxone interaction in the central cholinergic system: the influence of subcortical lesioning and electrical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Depression by morphine of the resting and evoked release of [3H]-acetylcholine from the cat caudate nucleus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Enhanced Utilization of Brain Acetylcholine during Morphine Withdrawal in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Effect of selective opiate antagonists on striatal acetylcholine and dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Fentanyl and morphine, but not remifentanil, inhibit acetylcholine release in pontine regions modulating arousal.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Morphine effects on human REM state, waking state and NREM sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Human sleep during chronic morphine intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

REM Sleep Induction by Physostigmine Infusion During Sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Effect of physostigmine on morphine-induced postoperative pain and somnolence.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

The reversal of epidural morphine induced somnolence with physostigmine.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

A double-blind trial of the analgesic properties of physostigmine in postoperative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Physostigmine antagonizes morphine-induced respiratory depression but not analgesia in dogs and rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Effects of morphine and physostigmine on the ventilatory response to carbon dioxide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Antagonism of morphine-induced respiratory depression by novel anticholinesterase agents

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Antinociception opioids and the cholinergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Phase I safety assessment of intrathecal neostigmine methylsulfate in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Anticholinesterase drugs in the treatment of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Tetrahydroaminoacridine (THA) in Alzheimer's disease: An assessment of attentional and mnemonic function using CANTAB

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Safety of tacrine: clinical trials, treatment IND, and postmarketing experience

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Clinical profile of donepezil in the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Donepezil for postoperative delirium associated with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Donepezil improves symptoms of delirium in dementia: implications for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Opioid rotation for cancer pain: rationale and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Opioid rotation for toxicity reduction in terminal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Reversal of tricyclic-overdosage-induced central anticholinergic syndrome by physostigmine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

A summary of mechanistic hypotheses of gabapentin pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Cognitive functions of cortical ACh: lessons from studies on trans-synaptic modulation of activated efflux

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Methadone in the management of cancer pain: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Physiological and Psychological Effects of Methadone in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Neuropsychological impairment in opiate addicts: risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Central cholinergic action produces antagonism to ketamine anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Physostigmine in recovery from anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Changes in cortical nicotinic acetylcholine receptor numbers following unilateral destruction of pyramidal neurones by intrastriatal volkensin injection

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Cholinomimetics Increase Glutamate Outflow via an Action on the Corticostriatal Pathway: Implications for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Effects of narcotic analgesics and antagonists on the in vivo release of acetylcholine from the cerebral cortex of the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Systemic physostigmine increases the antinociceptive effect of spinal morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Influence of hemicholinium (HC-3) on morphine analgesia, tolerance, physical dependence and on brain acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

The role of the cholinergic system in the development of increased naloxone potency in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Treatment of Intractable Pain with Morphine and Tetrahydroaminacrine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Interaction between intrathecal neostigmine and epidural clonidine in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

A multi-center study of intrathecal neostigmine for analgesia following vaginal hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Study of three different doses of epidural neostigmine coadministered with lidocaine for postoperative analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Postoperative analgesic effect of intrathecal neostigmine and its influence on spinal anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Intrathecal neostigmine for postoperative analgesia after orthopedic surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

The assessment of pain intensity in patients with cognitive failure: A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Delirium as a contributing factor to "crescendo" pain: three case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Opioid analgesics: comparative features and prescribing guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

Arousal systems and attentional processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900270-6

7 January 2021

10.1016/S0885-3924(01)00270-6

Identifiers

DOI

1 reference

25 November 2017

1 reference